Resource for Macromolecular Modeling and Visualization

总结 P41生物医学技术研究资源的主要使命是进行大分子建模和 生物信息学（P41-GM 104601）在过去的三十年里一直在发展最先进的计算能力， 生物分子和细胞模拟和可视化技术，以高效，经济， 用户友好的软件解决方案，并免费向生物医学界传播。资源 为需要整合分子和生物医学科学家提供了高质量，严格的研究。 细胞建模，模拟和可视化研究，不仅在不同的学术机构，而且 工业上目前使用的是VMD和NAMD两种导航软件及其辅助插件 超过125，000名用户，并收到了惊人的57，000次引用（2018-2021年为19，711次 单独），反映了资源开发的技术和程序的大量使用，及其子系统， 规模经济。资源与生物医学界的伙伴关系导致了2020年 ACM Gordon Bell COVID-19研究特别奖。在R24运作模式下， 该资源将确保其软件解决方案保持最新，并可供其大型用户使用， 现有和即将推出的硬件平台通常用于地方和机构级别以及国家超级 计算中心，其中很大一部分时间是由生物医学研究人员使用 资源的方案。鉴于这些计划的关键地位，几个主要的超级计算中心以及 由于主要硬件供应商已与资源建立了牢固的关系，甚至直接支持 软件开发和优化。此外，资源将通过以下方式确保其方案的效用： 对准则的适用性至关重要和/或社区要求的算法更改/更新。 该资源还将维持和扩大其全面的用户培训计划， 现有的大量在线教程、案例研究和实践研讨会。另一项主要活动是 资源将继续支持其用户正确有效地应用软件程序 通过客户支持服务以及扩展和升级程序的文档。R24 将通过监测持续评估高分子建模和可视化资源 定量指标，例如其活跃用户（多个版本软件的用户）和引用数量， 通过定期进行用户调查，要求用户社区提供投入，这也将有助于确定 最关键的功能和改进，以及外部咨询委员会的技术投入。

SUMMARY The main mission of the P41 Biomedical Technology Research Resource for Macromolecular Modeling and Bioinformatics (P41-GM104601) over the last three decades has been developing state of the art computational technologies for biomolecular and cell simulations and visualization, implementing them in efficient, economical, user-friendly software solutions, and disseminating them to the biomedical community at no cost. The Resource has enabled high-quality, rigorous research for the biomedical scientists who need to integrate molecular and cell modeling, simulation, and visualization in their research, not only at diverse academic institutions, but also in industry. The flagship software programs, VMD and NAMD and their auxiliary plugins, are used currently by more than 125,000 users and have received a staggering number of 57,000 citations (19,711 in 2018-2021 alone), reflecting the massive use of the technologies and programs developed by the Resource, and its sub- stantial economies of scale. The Resource's partnership with the biomedical community resulted in the 2020 ACM Gordon Bell Special Prize for COVID-19 Research. Under the R24 mode of operation, a major goal of the Resource will be to ensure that its software solutions remain current and available to its large user base on existing and upcoming hardware platforms commonly used at local and institutional levels, and at national super- computing centers, where a large fraction of the overall time is consumed by biomedical researchers using the Resource's programs. Given the key position of these programs, several major supercomputing centers as well as major hardware vendors have established strong relationships with the Resource, even directly supporting software development and optimization. In addition, the Resource will ensure the utility of its programs by includ- ing algorithmic changes/updates that are critical to applicability of the codes and/or demanded by the community. The Resource will also sustain and expand its comprehensive user training program, empowered by an already existing, large collection of online tutorials, case studies, and hands-on workshops. Another major activity of the Resource will be to continue to support its users in the proper and efficient application of the software programs through customer support services and expanding and upgrading the documentation for the programs. The R24 Resource for Macromolecular Modeling and Visualization will be evaluated on a continuous basis by monitoring quantitative metrics such as the number of its active users (users of multiple versions of software) and citations, by conducting regular user surveys requesting input from the user community which will also assist in identifying most critical features and improvements, and by the technical input from the external advisory board.